Health in Tech, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
Health In Tech reported a year-over-year decrease in GAAP revenue for Q2 2026 due to a new carrier onboarding timing shift, but highlighted significant growth in contracted and pipeline revenue as key indicators of future performance.
NASDAQ
Health In Tech, Inc. presented an investor deck on August 13, 2026, detailing its AI-powered marketplace for SMB self-funded health plans, while acknowledging recent revenue declines and net losses.
NASDAQ
Health In Tech announced its second quarter 2026 financial results, reporting a decrease in revenue and a net loss, though it highlighted growth in distribution partners and a substantial revenue pipeline.
NASDAQ
Health In Tech, Inc. published an updated investor presentation detailing its AI-powered marketplace platform for self-funded health plans.
NASDAQ
Health In Tech announced its first quarter 2026 financial results, showing a 9.4% revenue increase to $8.8 million, while reiterating its full-year revenue guidance of $45 million to $50 million.
NASDAQ
Dustin Plantholt departs as Chief AI & Marketing Officer, transitioning to an independent consulting role.
NASDAQ
Health In Tech, Inc. presented its AI-powered marketplace platform for self-funded health plans, reporting strong 2025 financial results and optimistic 2026 revenue guidance.
NASDAQ
Health In Tech, an AI-enabled InsurTech platform company, announced the closing of a $7.0 million private investment in public equity financing to fund strategic growth initiatives.
NASDAQ
Health In Tech, an AI-enabled InsurTech platform, announced a $7.0 million private placement of common stock to fund sales expansion and technology development.
NASDAQ
Health In Tech announced robust full-year 2025 financial results, including significant revenue and Adjusted EBITDA growth, alongside an optimistic revenue outlook for 2026.
NASDAQ
Health In Tech's executive management and Board of Directors voluntarily extended their share lock-up period by six months, demonstrating confidence in the company's future.
NASDAQ
Health In Tech, Inc. announced the termination of its Chief Technology Officer, Imran Yousuf, effective November 25, 2025.
NASDAQ
Health In Tech, Inc. announced robust third-quarter 2025 financial results, with revenue up 90% year-over-year, driven by expanded distribution and new platform capabilities.
NASDAQ
Health In Tech announced strong third-quarter 2025 financial results, with revenue up 90% year-over-year and significant growth in enrolled employees and distribution partners.
NASDAQ
Health In Tech, Inc. announced robust Q3 2025 financial results with significant revenue and Adjusted EBITDA growth, alongside a strategic partnership to develop a blockchain-enabled healthcare claims platform.
NASDAQ
Health In Tech, Inc. announced the results of its 2025 Annual Meeting of Stockholders, where all director nominees were re-elected, and an amendment to the equity incentive plan was approved.
NASDAQ
Health In Tech, Inc. granted restricted stock awards to its CEO and CFO tied to the development and launch of a new strategic initiative.
NASDAQ
Health In Tech, Inc. approved restricted stock awards for its CEO, CFO, and CTO, tied to the development and launch of two new strategic programs.
NASDAQ
Health In Tech, Inc. announced the termination of Chief Operating Officer Chris Kurtenbachs' at-will employment, effective July 22, 2025.
NASDAQ
Health In Tech, Inc. announced robust financial results for Q2 and the first half of 2025, showcasing significant year-over-year growth in revenue and Adjusted EBITDA, fueled by its innovative self-funded healthcare platform.
NASDAQ
Health In Tech announced robust second quarter 2025 financial results, reporting $9.3 million in revenue, an 86% year-over-year increase, alongside significant growth in adjusted EBITDA and expanded distribution partnerships.
NASDAQ
Health In Tech, Inc. received a notification from Nasdaq regarding non-compliance with the minimum bid price requirement, potentially leading to delisting.
NASDAQ
Health In Tech, Inc. reports the resignation of Lynn Liang from its Board of Directors and a subsequent reduction in the board's size, both effective April 18, 2025.
NASDAQ
Health In Tech is leveraging its insurance tech platform to simplify healthcare processes through vertical integration, automation, and process streamlining, targeting the $4.5 trillion healthcare industry.
NASDAQ
Health In Tech reports a significant increase in revenue and income before income taxes for the first quarter of 2025, driven by strong market demand and strategic initiatives.
NASDAQ
Health In Tech, an Insurtech platform company, has appointed Sanjay Shrestha to its Board of Directors, effective immediately.
NASDAQ
Health In Tech, Inc. releases an investor presentation detailing its business model, recent developments, and financial performance, including key executive appointments and a focus on AI-driven solutions in the healthcare insurance market.
NASDAQ
Health In Tech reports $19.5 million in total audited revenue for 2024, marking a 1.8% year-over-year increase, alongside strategic investments in technology and infrastructure.
NASDAQ
Health In Tech, Inc. updated its bylaws on February 25, 2025, to increase the number of authorized directors from seven to eleven and modify the terms of directors.
NASDAQ
8-K: Health In Tech Prices Initial Public Offering at $4.00 Per Share, Trading to Commence on Nasdaq
Health In Tech, an Insurtech platform, has successfully priced its initial public offering of 2.3 million shares at $4.00 per share, with trading expected to begin on the Nasdaq Capital Market on December 23, 2024.